Relationship between serum nesfatin-1 with mother's anthropometric indices at 18-24 months postpartum in terms of mode of delivery: a nested case- control study

Document Type : Original Article

Authors

1 M.Sc. in Midwifery, Department of Midwifery and Reproductive Health, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

2 Assistant Professor, Department of Midwifery and Reproductive Health, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

3 Instructor, Department of Nursing, Esfarayen School of Medical Sciences, Esfarayen, Iran.

Abstract

Introduction: According to the protective role of Nesfatin-1’s in obesity, this study was performed with aim to investigate the relationship between serum Nesfatin-1 with mothers' anthropometric indices at 18-24 months postpartum in terms of mode of delivery.
Methods: This nested case-control study was performed on 42 pregnant women with gestational age of 28-32 weeks who had referred to the Mahdieh hospital in Tehran for prenatal care in 2014. Serum Nesfatine-1 levels were measured during 28-32 weeks of gestation and 24 hours after delivery using ELISA method. Then, the subjects were divided in two groups of case (natural vaginal delivery) and control (cesarean section). Anthropometric indices were measured two times in the third trimester of pregnancy and then 18-24 months after delivery. Data were analyzed by SPSS software (version 20) and Chi–Square, linear regression, Spearman, Wilcoxon Signed-Rank Test, and Mann-Whitney U test. P<0.05 was considered statistically significant.
Results: Serum level of nsafatin-1 after cesarean delivery had negative significant correlations with BMI at third trimester of pregnancy (P = 0.001, r = -0.66), postpartum follow-up BMI (P = 0.004, r = -0.59) and postpartum weight retention (P = 0.05, r = -0.42). Serum nesfatin -1 was a significant independent predictor of postpartum follow-up BMI (P <0.01). Serum nsafatin-1 had no significant relationship with weight gain during pregnancy and anthropometric indices in NVD group (P> 0.05).
Conclusion: It seems that lack of increase of Nesfatin-1 after elective cesarean section will predispose the mother to obesity in the distant future in postpartum period.

Keywords

References

  1. Shao HH, Hwang LC, Huang JP, Hsu HY. Postpartum Weight Retention Risk Factors in a Taiwanese Cohort Study. Obes Facts 2018; 11(1):37-45.
  2. Endres LK, Straub H, McKinney C, Plunkett B, Minkovitz CS, Schetter CD, et al. Postpartum weight retention risk factors and relationship to obesity at one year. Obstet Gynecol 2015; 125(1):144-52.
  3. Weiss JL, Malone FD, Emig D, Ball RH, Nyberg DA, Comstock CH, et al. Obesity, obstetric complications and cesarean delivery rate–a population-based screening study. Am J Obstet Gynecol 2004; 190(4):1091-7.
  4. Tan BK, Hallschmid M, Kern W, Lehnert H, Randeva HS. Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment. J Clin Endocrinol Metab 2011; 96(4):E669-E73.
  5. Mashhad Taraqi AS, Tehranian N, Roudbaneh SP, Esmaeilzadeh MS, Kazemnejad A, Aghoozi MF, et al. Visfatin as a predictor for growth of fetus and infant. Turk J Obstet Gynecol 2018; 15(2):80-86.
  6. Saber A, Tehranian N, Esmailzade MS, Pourali Roudbaneh Sh. Relationship between Serum visfatin with anthropometric indices and maternal gestational weight gain. Iran J Obstet Gynecol Infertil 2019; 22(5):43-51.
  7. Saldanha JF, Carrero JJ, Lobo JC, Stockler-Pinto MB, Leal VO, Calixto A, et al. The newly identified anorexigenic adipokine nesfatin-1 in hemodialysis patients: Are there associations with food intake, body composition and inflammation? Regul Pept 2012; 173(1):82-5.
  8. Su Y, Zhang J, Tang Y, Bi F, Liu JN. The novel function of nesfatin-1: anti-hyperglycemia. Biochem Biophys Res Commun 2010; 391(1):1039-42.
  9. Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006; 443(7112):709-12.
  10. García-Galiano D, Navarro VM, Roa J, Ruiz-Pino F, Sánchez-Garrido MA, Pineda R, et al. The Anorexigenic Neuropeptide, Nesfatin-1, Is Indispensable for Normal Puberty Onset in the Female Rat. J Neurosci 2010; 30(23):7783-92.
  11. Zhang AQ, Li XL, Jiang CY, Lin L, Shi RH, Chen JD, et al. Expression of nesfatin-1/NUCB2 in rodent digestive system. World J Gastroenterol 2010; 16(14):1735-41.
  12. Bonnet MS, Pecchi E, Trouslard J, Jean A, Dallaporta M, Troadec JD. Central nesfatin-1-expressing neurons are sensitive to peripheral inflammatory stimulus. J Neuroinflammation 2009; 6:27.
  13. Zhang Z, Li L, Yang M, Liu H, Boden G, Yang G. Increased plasma levels of nesfatin-1 in patients with newly diagnosed type2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2012; 120(2):91-5.
  14. Li QC, Wang HY, Chen X, Guan HZ, Jiang ZY. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 2010; 159(1-3):72-7.
  15. Aksu O, Aydın B, Doguç DK, Ilhan I, Ozturk O, Altuntas A, et al. The evaluation of Nesfatin-1 levels in patients with OSAS associated with metabolic syndrome. J Endocrinol Invest 2015; 38(4):463-9.
  16. Abaci A, Catli G, Anik A, Kume T, Bober E. The relation of serum nesfatin‐1 level with metabolic and clinical parameters in obese and healthy children. Pediatr Diabetes 2013; 14(3):189-95.
  17. Psilopanagioti A, Nikou S, Papadaki H. Nucleobindin-2/Nesfatin-1 in the Human Hypothalamus Is Reduced in Obese Subjects and Colocalizes with Oxytocin, Vasopressin, Melanin-Concentrating Hormone, and Cocaine-and Amphetamine-Regulated Transcript. Neuroendocrinology 2019; 108(3):190-200.
  18. Mirzaei K, Hossein-nezhad A, Keshavarz SA, Koohdani F, Eshraghian MR, Saboor-Yaraghi AA, et al. Association of nesfatin-1 level with body composition, dietary intake and resting metabolic rate in obese and morbid obese subjects. Diabetes Metab Syndr 2015; 9(4):292-8.
  19. Majorczyk M, Staszkiewicz M, Szklarczyk J, Major P, Pisarska M, Wysocki M, et al. The influence of bariatric surgery on serum levels of irisin and nesfatin-1. Acta Chir Belg 2019; 119(6):363-369.
  20. Baykan H, Baykan O, Durmaz O, Gulsah OE, Kara H, Gorgulu SA, et al. Plasma Nesfatin-1 Levels and its Relationship with Anxiety Levels in Obesity Diagnosed Population: A Controlled Study. Clinical and Experimental Health Sciences 2018; 9(2):107-11.
  21. Zhang T, Wang M, Liu L, He B, Hu J, Wang Y. Hypothalamic nesfatin-1 mediates feeding behavior via MC3/4R-ERK signaling pathway afterweight loss in obese Sprague-Dawley rats. Peptides 2019; 119:170080.
  22. Houben ML, Nikkels PG, van Bleek GM, Visser GH, Rovers MM, Kessel H, et al. The association between intrauterine inflammation and spontaneous vaginal delivery at term: a cross-sectional study. PLoS One 2009; 4(8):e6572.
  23. Davari M, Maracy MR, Ghorashi Z, Mokhtari M. The Relationship between Socioeconomic Status and the Prevalence of Elective Cesarean Section in Nulliparous Women in Niknafs Teaching Center, Rafsanjan, Iran. Health Information Management 2012; 8(7):958-65.
  24. Unal ER, Cierny JT, Roedner C, Newman R, Goetzl L. Maternal inflammation in spontaneous term labor. Am J Obstet Gynecol 2011; 204(3):223.e1-5.
  25. Neal JL, Lamp JM, Lowe NK, Gillespie SL, Sinnott LT, McCarthy DO. Differences in inflammatory markers between nulliparous women admitted to hospitals in preactive vs active labor. Am J Obstet Gynecol 2015; 212(1):68.e1-8.
  26. Shimizu H, Ohsaki A, Oh-I S, Okada S, Mori M. A new anorexigenic protein, nesfatin-1. Peptides 2009; 30(5):995-8.
  27. Tsuchiya T, Shimizu H, Yamada M, Osaki A, Oh-I S, Ariyama Y, et al. Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf) 2010; 73(4):484-90.
  28. Zhang C, Wang Y, Wang Y, Li J, Liu R, Liu H. Decreased levels of serum nesfatin-1 in patients with preeclampsia. Biomarkers 2014; 19(5):402-6.
  29. Li QC, Wang HY, Chen X, Guan HZ, Jiang ZY. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 2010; 159(1-3):72-7.
The Iranian Journal of Obstetrics, Gynecology and Infertility
Volume 23, Issue 7
September 2020
Pages 59-68

Files

Share

How to cite

Statistics